Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Other financing activities (2016 - 2025)

iBio (IBIO) has disclosed Other financing activities for 11 consecutive years, with -$46.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A to -$46.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.7 million, a 21423.53% increase, with the full-year FY2025 number at $6.2 million, up 25925.0% from a year prior.
  • Other financing activities was -$46.3 million for Q4 2025 at iBio, down from $50.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $50.0 million in Q3 2025 to a low of -$46.3 million in Q4 2025.
  • A 5-year average of $456400.0 and a median of $14500.0 in 2022 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: decreased 23.53% in 2022, then tumbled 285.71% in 2023.
  • iBio's Other financing activities stood at -$17000.0 in 2021, then decreased by 23.53% to -$21000.0 in 2022, then crashed by 285.71% to -$81000.0 in 2023, then soared by 120.99% to $17000.0 in 2024, then crashed by 272729.41% to -$46.3 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Other financing activities are -$46.3 million (Q4 2025), $50.0 million (Q3 2025), and $17000.0 (Q2 2024).